Hospital Introduction & Medical Care Guide

The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU) was founded in 1947 as the first affiliated hospital of Zhejiang University. It is a large Grade 3 Class A comprehensive hospital integrating medical care, teaching, research, prevention, and management. The hospital serves as the National Center for Infectious Diseases Medicine, the leading unit of the comprehensive national regional medical center, and one of the first batch of pilot units for national medical center creation (mentoring category). It is also one of 14 pilot units for high-quality development of public hospitals nationwide. With six campuses (Qingchun, Yuhang/Headquarters Phase I, Zhijiang, Chengzhan, Daxuelu, and Qiantang), the hospital has over 5,000 authorized beds and nearly 10,000 staff members. In the 2022 national tertiary public hospital performance assessment, it ranked 2nd nationwide, consistently achieving A++ rating (top 1%). It ranked 10th in the Fudan version of China Hospital Rankings and 5th in Science and Technology Metrics. The hospital leverages infectious diseases and organ transplantation as its two peak disciplines to drive a cluster of nationally renowned plateau disciplines, pioneering nationwide experience in specialized precision treatment and collaborative diagnosis and treatment of difficult diseases.

器官移植（Organ Transplantation），传染病学（Infectious Diseases），肝胆胰外科（Hepatobiliary and Pancreatic Surgery）

肝胆胰外科（Hepatobiliary and Pancreatic Surgery），传染病学科（Infectious Diseases），血液病科（Hematology），肾脏病中心（Nephrology），心血管内科（Cardiology），消化内科（Gastroenterology），重症医学科（Critical Care Medicine），临床药学（Clinical Pharmacy）

National Status and International Recognition
1. National Center for Infectious Diseases Medicine: Approved in 2021, representing the highest national level for infectious disease science and technology innovation and transformation, undertaking over 95% of severe COVID-19 treatment nationwide.
2. National Medical Center Creation Unit: First batch "mentoring category" national medical center creation unit, leading unit of comprehensive national regional medical center.
3. National Ranking: Ranked 2nd nationwide in the 2022 national tertiary public hospital performance assessment, consistently achieving A++ rating (top 1%); 10th in Fudan Rankings; 5th in Science and Technology Metrics.
4. Research Strength: 2 national key disciplines, 28 national clinical key specialties (14th Five-Year Plan period), 1 national key laboratory (National Key Laboratory for Severe Infectious Disease Diagnosis and Treatment), 1 national clinical research center, 1 NSFC basic science center. 1 Special Prize of National Science and Technology Progress Award (the only one in China's education and health system), 2 First Prizes, and 9 Second Prizes. Over 600 high-level papers published in Nature, Cell, Science, NEJM, The Lancet, etc.
5. International Recognition: Collaborations with over 50 world-leading institutions including Johns Hopkins Hospital and University of Pittsburgh Medical Center; China's first surgical residency training base certified by Johns Hopkins University; leading unit of Zhejiang Provincial Hospital Association Foreign Affairs Committee.

Core Departments and Global Leadership
1. Hepatobiliary and Pancreatic Surgery/Organ Transplantation Center: National key discipline and national clinical key specialty, one of China's largest hepatobiliary and pancreatic centers (14 wards with over 600 beds). Led by Academician Zheng Shusen, with over 3,000 liver transplants performed, creating Asia's longest combined pancreas-kidney transplant survival record (18 years) and China's longest combined liver-kidney transplant survival record (17 years). Established the internationally recognized "Hangzhou Criteria" for liver transplantation in liver cancer. Global leader in Da Vinci robotic single-machine surgical volume.
2. Infectious Diseases/Infectious Disease Department: National key discipline led by Academician Li Lanjuan. The supporting discipline of the National Center for Infectious Diseases Medicine, ranking 1st nationwide in the China Hospital Science and Technology Metrics Rankings for seven consecutive years (2014-2020). Created the "Li's Artificial Liver Support System," treating over 3,000 cases of severe hepatitis. Won the National Science and Technology Progress Special Prize for prevention and treatment of emerging infectious diseases including H7N9 avian influenza and COVID-19.
3. Hematology: National clinical key specialty, internationally advanced in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation. Created an integrated leukemia treatment system, leading nationwide in unrelated allogeneic bone marrow transplantation.
4. Nephrology Center: National clinical key specialty, end-stage kidney disease replacement therapy won the National Science and Technology Progress Second Prize, renowned in kidney transplantation and blood purification.
5. Cardiology: National clinical key specialty, nationally leading in complex coronary disease, arrhythmia, and structural heart disease intervention.
6. Gastroenterology: National clinical key specialty, ranking 1st nationwide in Science and Technology Metrics, leading in inflammatory bowel disease, digestive endoscopy, and early gastric cancer diagnosis.
7. Critical Care Medicine: National clinical key specialty, won the National Science and Technology Progress Second Prize for severe acute pancreatitis and sepsis early warning and treatment.
8. Clinical Pharmacy: National clinical key specialty, building a clinical pharmacy benchmark discipline oriented toward excellence.